Sigyn Therapeutics, Inc. to Present at the LD Micro Main Event XIX
Sigyn Therapeutics (OTCQB: SIGY) will present at LD Micro Main Event XIX on Tuesday, October 21, 2025 at 4:00 PM PT at the Hotel del Coronado in San Diego. CEO and inventor Jim Joyce will deliver the presentation and the company will be available for investor meetings during the three-day event running October 19–21, 2025.
The conference features ~120 companies presenting in half-hour slots and includes keynotes, company presentations, one-on-one investor meetings, and a closing reception. A virtual registration option is available for the presentation.
Sigyn Therapeutics (OTCQB: SIGY) parteciperà a LD Micro Main Event XIX il martedì 21 ottobre 2025 alle ore 16:00 PT presso l'Hotel del Coronado a San Diego. Il CEO e inventore Jim Joyce terrà la presentazione e l'azienda sarà disponibile per incontri con gli investitori durante l'evento di tre giorni in programma dal 19 al 21 ottobre 2025.
La conferenza prevede circa 120 aziende che presenteranno in slot di mezz'ora e comprende discorsi principali, presentazioni aziendali, incontri one-to-one con gli investitori e una reception di chiusura. È disponibile un'opzione di registrazione virtuale per la presentazione.
Sigyn Therapeutics (OTCQB: SIGY) participará en LD Micro Main Event XIX el martes 21 de octubre de 2025 a las 4:00 PM PT en el Hotel del Coronado en San Diego. El CEO e inventor Jim Joyce ofrecerá la presentación y la empresa estará disponible para reuniones con inversionistas durante el evento de tres días que se llevará a cabo del 19 al 21 de octubre de 2025.
La conferencia contará con ~120 empresas que presentarán en sesiones de media hora e incluirá intervenciones magistrales, presentaciones de empresas, reuniones uno a uno con inversionistas y una recepción de cierre. Existe una opción de registro virtual para la presentación.
Sigyn Therapeutics (OTCQB: SIGY)는 LD Micro Main Event XIX에서 2025년 10월 21일 화요일 오후 4시 PT에 샌디에이고의 Hotel del Coronado에서 발표합니다. CEO 겸 발명가 Jim Joyce가 발표를 주도하고 이 회사는 2025년 10월 19일부터 21일까지 열리는 3일간의 행사 동안 투자자 미팅을 가질 수 있습니다.
컨퍼런스는 약 120개사가 30분 간격으로 발표하며 기조 발표, 기업 프리젠테이션, 투자자와의 일대일 미팅, 폐막 리셉션을 포함합니다. 발표를 위한 가상 등록 옵션이 제공됩니다.
Sigyn Therapeutics (OTCQB: SIGY) sera présent à LD Micro Main Event XIX le Mardi 21 octobre 2025 à 16h00 PT à l'hôtel del Coronado à San Diego. Le PDG et inventeur Jim Joyce assurera la présentation et l'entreprise sera disponible pour des réunions avec les investisseurs pendant les trois jours de l'événement du 19 au 21 octobre 2025.
La conférence réunit environ 120 entreprises qui présenteront par créneaux de trente minutes et comprend des allocutions, des présentations d'entreprises, des réunions investisseurs en tête-à-tête et une réception de clôture. Une option d'inscription virtuelle est disponible pour la présentation.
Sigyn Therapeutics (OTCQB: SIGY) wird beim LD Micro Main Event XIX am Dienstag, dem 21. Oktober 2025 um 16:00 PT im Hotel del Coronado in San Diego präsentieren. CEO und Erfinder Jim Joyce wird die Präsentation halten und das Unternehmen wird während der dreitägigen Veranstaltung vom 19. bis 21. Oktober 2025 für Investoren-Gespräche zur Verfügung stehen.
Die Konferenz bietet etwa 120 Unternehmen, die in halbstündigen Slots präsentieren, und umfasst Keynotes, Unternehmenspräsentationen, One-on-One-Investorenmeetings und einen Abschlussabend. Eine virtuelle Registrierungsoption ist für die Präsentation verfügbar.
Sigyn Therapeutics (OTCQB: SIGY) ستقدم في LD Micro Main Event XIX يوم الثلاثاء 21 أكتوبر 2025 الساعة 4:00 مساءً بتوقيت المحيط الهادئ في فندق ديل كورونادو في سان دييغو. سيقدم الرئيس التنفيذي والمخترع Jim Joyce العرض وستكون الشركة متاحة لعقد اجتماعات مع المستثمرين خلال الحدث الذي يستمر ثلاثة أيام من 19 إلى 21 أكتوبر 2025.
تضم المؤتمر نحو 120 شركة ستعرض في فترات زمنية نصف ساعة وتشمل كلمات رئيسية، عروض الشركات، اجتماعات المستثمرين وجهاً لوجه، وحفل استقبال ختامي. خيار التسجيل الافتراضي متاح لتقديم العرض.
Sigyn Therapeutics (OTCQB: SIGY) 将在 LD Micro Main Event XIX 于 2025年10月21日星期二太平洋夏令时下午4:00 在圣地亚哥的 Coronado 酒店举行的活动中进行陈述。首席执行官兼发明人 Jim Joyce 将进行演讲，公司将在2025年10月19日至21日的三天活动期间提供投资者会谈。
该会议约有120家公司在每半小时的时段内进行陈述，包含主旨致辞、公司介绍、投资者一对一会谈以及闭幕招待会。提供虚拟注册选项以参加演讲。
- None.
- None.
Presentation on Tuesday, October 21st at 4:00 PM PT
San Diego, California--(Newsfile Corp. - October 17, 2025) - Sigyn Therapeutics, Inc. (OTCQB: SIGY), a developer of dialysis-like therapies to address cardiovascular disease and cancer, announced today that it will be presenting at the 19th annual Main Event on Tuesday, October 21st at 4:00 PM PT at the Hotel del Coronado in San Diego, California. Jim Joyce, CEO and Inventor will be giving the presentation.
"The Main Event is a culmination of over 25 years of hard work and passion for small company investing. There is no organization on planet Earth that cares more about small companies succeeding than LD. To be able to connect with our community in one of the most beautiful settings imaginable brings me considerable joy. We look forward to welcoming all of our patrons and ensuring that they have a wonderful time," stated Chris Lahiji, Founder of LD Micro.
Event: LD Micro Main Event XIX
Date: Tuesday, October 21st
Time: 4:00 PM
Register to watch the virtual presentation here.
Summary of LD Micro Main Event XIX
The 2025 LD Micro Main Event XIX will run from October 19th to the 21st at the Hotel del Coronado in San Diego, California.
The first day will consist of registration, keynote speakers, and some gorgeous views of the Pacific. It will be followed by two full days of company presentations and one-on-one investor meetings concluded with a closing reception.
This three-day event will feature around 120 companies, presenting in half-hour increments, and attending private meetings with investors.
About Sigyn Therapeutics, Inc.
Sigyn Therapeutics is developing dialysis-like therapies to address cardiovascular disease and cancer. Sigyn CardioDialysisTM is a first-in-class blood purification technology being advanced to treat cardiovascular disease, the leading cause of global deaths. CardioDialysisTM is designed to reduce the circulating presence of inflammatory molecules that drive cardiovascular disease progression while simultaneously targeting cholesterol transporting lipoproteins that contribute to heart attacks, strokes, and other major adverse cardiovascular events (MACE). The Company’s development pipeline includes ImmunePrep(TM) to optimize the delivery of immunotherapeutic antibodies; ChemoPrep(TM) to enhance the targeted delivery of chemotherapy; and ChemoPure(TM) to reduce chemotherapy toxicity. To learn more about Sigyn Therapeutics, visit: www.SigynTherapeutics.com
About LD Micro
LD Micro is dedicated to being the definitive resource in the small-cap space. From its industry-recognized index and robust data to hosting some of the most influential events each year, LD Micro’s mission is to provide unparalleled access and insight for those seeking the next generation of great companies.
To learn more about LD Micro, visit:
http://www.ldmicro.com
To learn more about Freedom US Markets LLC, visit:
https://www.freedomcapmkts.com/
To present or register, please contact registration@ldmicro.com.
For further information on Sigyn Therapeutics, Inc.:
Sigyn Therapeutics, Inc.
Jim Joyce
619-368-2000
jj@sigyntherapeutics.com
www.sigyntherapeutics.com
FAQ
When will Sigyn Therapeutics (SIGY) present at LD Micro Main Event XIX?
Who will present for Sigyn Therapeutics (SIGY) at the October 21, 2025 session?
Can investors watch the Sigyn Therapeutics (SIGY) presentation virtually on October 21, 2025?
What is the schedule and location for LD Micro Main Event XIX where SIGY will present?
How many companies will present at LD Micro Main Event XIX where SIGY is scheduled?
How long are company presentation slots at LD Micro Main Event XIX for SIGY?
